← All companies

LGND — LIGAND PHARMACEUTICALS INC

Materials · Pharmaceutical Preparations · Nasdaq

CIK 0000886163 · FYE 1231 · All Form 4 filings on EDGAR ↗

Formerly: LIGAND PHARMACEUTICALS (until 1994-09-13)

1Insiders filing

5Transactions

+$0Reported buys

−$1.4MReported sells

0Cluster events

Window in data: 2026-09-03 → 2026-09-03 · Data as of 2026-09-09

Insiders

Insider	Role	Txns	Reported value
Reardon Andrew	CLO & Secretary	5	$1.4M

Transaction history

Filing date	Trade date	Ticker	Insider	Type	Shares	Price	Value	Cluster
2026-09-08	2026-09-03	LGND	Reardon Andrew CLO & Secretary 10b5-1	S	300	$283.99	−$85k	—
2026-09-08	2026-09-03	LGND	Reardon Andrew CLO & Secretary 10b5-1	S	1,800	$285.17	−$513k	—
2026-09-08	2026-09-03	LGND	Reardon Andrew CLO & Secretary 10b5-1	S	2,115	$286.36	−$606k	—
2026-09-08	2026-09-03	LGND	Reardon Andrew CLO & Secretary 10b5-1	S	385	$287.53	−$111k	—
2026-09-08	2026-09-03	LGND	Reardon Andrew CLO & Secretary 10b5-1	S	400	$288.98	−$116k	—

Known data limitations

Form 4 lag: insiders have 2 business days to file after a trade (weekends and holidays extend this), and this site re-ingests once daily — a transaction can appear here roughly three business days after it happened.
13F lag: quarterly 13F-HR holdings cover the prior quarter-end and are due 45 days after it — every institutional position shown here is at least 45 days old by construction, often more.
CUSIP→ticker gaps: 13F positions are reported by CUSIP; some holdings cannot be matched to a current ticker (delistings, corporate actions, thin metadata) and appear without one or are omitted from ticker-level views.
EDGAR timing variability: institutions file at different hours and days within their windows; amended filings (4/A, 13F-HR/A) can restate earlier periods, so historical aggregates may change between batches.

Insider Atlas is a descriptive research site, not investment advice — see the methodology for the full provenance chain.